Cognitive impairment and treatment strategies in patients with major depression and bipolar disorder

doi:10.3969/j.issn.1004-583X.2017.10.001

Abstract

Abstract: Cognitive impairment is a typical feature of mood disorders. Mood disorders include major depressive disorder (MDD) and bipolar disorder (BD). Cognitive impairment affects a patient's daily and social abilities. Therefore, in order to improve the quality of life, patients need to optimize their cognitive functions. In general, cognitive impairment develops as BD progresses, and cognitive impairment is more severe than depression. In this review， we discuss the differences of cognitive function in patients with MDD and BD. Four aspects were elaborated: ① comparison of cognitive function of MDD and BD patients； ② imaging identification of cognitive impairment； ③ factors affecting cognitive impairment； ④ therapeutic strategies for improving cognitive function.

Key words: bipolar disorder, cognitive impairment, treatment strategy

Wang Yongliang， Wang Xueyi. Cognitive impairment and treatment strategies in patients with major depression and bipolar disorder[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2017.10.001.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2017.10.001

https://huicui.hebmu.edu.cn/EN/Y2017/V32/I10/829

[1]	Zhang Jianan, Sun Linlin, Zhan Xiaoyan, Li Bing. Correlation between serum Vitamin B₁₂ and mild cognitive impairment in elderly patients with type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(1): 34-37.
[2]	Xiao Huangyi, Yuan Jiankun, Yan Ziyu, Zeng Wenshu, Lu Lanmo, Wang Jun. Effectiveness of cognitive interventions on elderly patients with amnestic mild cognitive impairment: A meta-analysis [J]. Clinical Focus, 2024, 39(1): 12-19.
[3]	Xin Yanhong, Lang Guiyan, Chen Ziwei, Wang Dongyu. Value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting cognitive impairment in patients with acute mild ischemic stroke [J]. Clinical Focus, 2023, 38(6): 504-509.
[4]	Jia Yangjuan, Han Ning, Guo Hui, Li Yanpeng, Li Cancan, Li Jianguo. Value of Mini Mental State Examination and Montreal Cognitive Assessment in screening mild vascular cognitive impairment at post-stroke [J]. Clinical Focus, 2023, 38(3): 221-226.
[5]	Guo Chang, Shen Huinan, Sun Yimeng, Wang Dongyu. Correlation between blood lipid and homocysteine and cognitive impairment in Parkinson's disease [J]. Clinical Focus, 2022, 37(2): 128-132.
[6]	Zhang Yuanyuana, Duan Junyingb, Zhang Yaxina, Liang Dongmeia, Liu Guoqinga, Li Yana. A sample research on prevalence and risk factors of amnestic mild cognitive impairment in elderly in Shijiazhuang [J]. Clinical Focus, 2020, 35(7): 610-615.
[7]	Wang Xuemei, Zhang Yuanyuan, Yu Hong, Yang Fengjuan, Li Yujie, Li Yan. Effect of computerized cognitive training in elderly with mild cognitive impairment: a metaanalysis [J]. Clinical Focus, 2019, 34(9): 843-849.
[8]	Sun Mei1, Hou Xiaoxia2, Jin Shanquan1, Shen Feifei1, Cheng Hong1. LGI1 antibodyrelated limbic encephalitis: a case report and literature review [J]. Clinical Focus, 2019, 34(3): 273-275.
[9]	Zhu Zhaozhang, Zhou Fanli, Lu Lan. Clinical study on the relationship between trimethylamine NOxide and mild cognitive impairment in young and middleaged patients with maintenance hemodialysis [J]. Clinical Focus, 2019, 34(11): 991-994.
[10]	Gao Lixia， Guo Huifang. Major advances in clinical research of rheumatic diseases of 2017 [J]. Clinical Focus, 2018, 33(1): 54-59,65.
[11]	Zhang Jie, Zhou Xiaohui, Luo Kun. Association between mild cognitive impairment and apolipoprotein E genetic polymorphism in Chinese population: a meta-analysis [J]. Clinical Focus, 2016, 31(3): 315-321.
[12]	Huang Yonglan;Zhang Hua;Chen Zhenhua;Yang Can;Zhu Zhixian. Application of drugs in treatment of 224 bipolar disorder patients [J]. Clinical Focus, 2015, 30(8): 935-937.
[13]	LI Chun-xiang;QIN Hua-hong;FENG Xiao-yun. Oxiracetam combined with nimodipine in treatment of vascular cognitive impairment:a clinical analysis [J]. Clinical Focus, 2014, 29(8): 858-860.
[14]	ZHAO Yuan-yuan;ZHAO Xiao-chuan;TAN Li;WANG Jin-cheng;JIN Gui-xing. Case-control study on executive function impairment in unipolar and bipolar depressive disorders [J]. Clinical Focus, 2014, 29(7): 769-770774.
[15]	GUO Hui-fang;GAO Li-xia. The main clinical progress in rheumatology disease during 2013 [J]. CLINICAL FOCUS, 2014, 29(3): 282-286.

Cognitive impairment and treatment strategies in patients with major depression and bipolar disorder

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments